SI1730315T1 - Polimorfizmi v genu NOD2/CARD15 - Google Patents

Polimorfizmi v genu NOD2/CARD15

Info

Publication number
SI1730315T1
SI1730315T1 SI200530850T SI200530850T SI1730315T1 SI 1730315 T1 SI1730315 T1 SI 1730315T1 SI 200530850 T SI200530850 T SI 200530850T SI 200530850 T SI200530850 T SI 200530850T SI 1730315 T1 SI1730315 T1 SI 1730315T1
Authority
SI
Slovenia
Prior art keywords
nod2
polymorphisms
card15 gene
methods
card15
Prior art date
Application number
SI200530850T
Other languages
English (en)
Inventor
Hanns-Georg Klein
Original Assignee
Klein Hanns Georg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klein Hanns Georg filed Critical Klein Hanns Georg
Publication of SI1730315T1 publication Critical patent/SI1730315T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
SI200530850T 2004-03-27 2005-03-29 Polimorfizmi v genu NOD2/CARD15 SI1730315T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004015143 2004-03-27
PCT/DE2005/000550 WO2005095640A1 (de) 2004-03-27 2005-03-29 Polymorphismen im nod2/card15 gen
EP05736111A EP1730315B1 (de) 2004-03-27 2005-03-29 Polymorphismen im nod2/card15 gen

Publications (1)

Publication Number Publication Date
SI1730315T1 true SI1730315T1 (sl) 2010-02-26

Family

ID=34965877

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200530850T SI1730315T1 (sl) 2004-03-27 2005-03-29 Polimorfizmi v genu NOD2/CARD15

Country Status (9)

Country Link
US (1) US7803535B2 (sl)
EP (1) EP1730315B1 (sl)
AT (1) ATE446385T1 (sl)
DE (2) DE502005008373D1 (sl)
DK (1) DK1730315T3 (sl)
ES (1) ES2336581T3 (sl)
PL (1) PL1730315T3 (sl)
SI (1) SI1730315T1 (sl)
WO (1) WO2005095640A1 (sl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10544459B2 (en) 2004-12-08 2020-01-28 Cedars-Sinai Medical Center Methods of using genetic variants for the diagnosis and treatment of inflammatory bowel disease
US11268149B2 (en) 2004-12-08 2022-03-08 Cedars-Sinai Medical Center Diagnosis and treatment of inflammatory bowel disease
WO2008109782A2 (en) * 2007-03-06 2008-09-12 Cedars-Sinai Medical Center Diagnosis of inflammatory bowel disease in children
JP2013509883A (ja) 2009-11-06 2013-03-21 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ 臓器移植患者における移植片拒絶反応の非侵襲的診断方法
US9540443B2 (en) 2011-01-26 2017-01-10 Kolltan Pharmaceuticals, Inc. Anti-kit antibodies
BR112015001459B1 (pt) 2012-07-25 2023-02-14 Celldex Therapeutics, Inc Anticorpo isolado ou fragmento do mesmo, conjugado, usos dos mesmos, composição farmacêutica, polinucleotídeo, vetor, célula hospedeira, célula isolada, kit, método in vitro para inibir atividade da kit, método para produzir um anticorpo
KR101530535B1 (ko) * 2013-06-13 2015-06-23 주식회사 마크로젠 이식편대숙주병 발병 위험성의 예측 방법, 예측용 조성물 및 키트
CN113975386A (zh) 2014-05-23 2022-01-28 塞尔德克斯医疗公司 嗜酸性粒细胞或肥大细胞相关病症的治疗
KR101541139B1 (ko) 2015-02-13 2015-08-07 주식회사 마크로젠 이식편대숙주병 발병 위험성의 예측 방법, 예측용 조성물 및 키트
KR101541141B1 (ko) 2015-06-25 2015-08-07 주식회사 마크로젠 이식편대숙주병 발병 위험성의 예측 방법, 예측용 조성물 및 키트
KR101593090B1 (ko) * 2015-06-25 2016-02-12 주식회사 마크로젠 이식편대숙주병 발병 위험성의 예측 방법, 예측용 조성물 및 키트
KR101541140B1 (ko) 2015-06-25 2015-08-07 주식회사 마크로젠 이식편대숙주병 발병 위험성의 예측 방법, 예측용 조성물 및 키트
KR101541142B1 (ko) 2015-06-25 2015-08-07 주식회사 마크로젠 이식편대숙주병 발병 위험성의 예측 방법, 예측용 조성물 및 키트

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002243415B2 (en) 2000-10-30 2007-05-24 Regents Of The University Of Michigan Nod2 nucleic acids and proteins
US7205107B2 (en) 2001-12-21 2007-04-17 Cytokine Pharmasciences, Inc. Macrophage migration inhibitory factor (MIF) promoter polymorphism in inflammatory disease
US20040053263A1 (en) * 2002-08-30 2004-03-18 Abreu Maria T. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease

Also Published As

Publication number Publication date
WO2005095640B1 (de) 2006-03-09
EP1730315A1 (de) 2006-12-13
WO2005095640A1 (de) 2005-10-13
US20070212694A1 (en) 2007-09-13
DK1730315T3 (da) 2010-03-08
US7803535B2 (en) 2010-09-28
ES2336581T3 (es) 2010-04-14
ATE446385T1 (de) 2009-11-15
EP1730315B1 (de) 2009-10-21
DE112005001317A5 (de) 2007-05-24
DE502005008373D1 (de) 2009-12-03
PL1730315T3 (pl) 2010-03-31

Similar Documents

Publication Publication Date Title
PL1730315T3 (pl) Polimorfizmy w genie NOD2/CARD15
WO2004066941A3 (en) Expression profiles for colon cancer and methods of use
WO2005059108A3 (en) Gene expression profiles and methods of use
DK1597391T3 (da) Anvendelse af intron-RNA til måling af genekspression
WO2006037064A3 (en) Mutant polymerases for sequencing and genotyping
WO2006138275A3 (en) Compositions and methods for treating and diagnosing cancer
EP1490489A4 (en) METHODS AND MEANS FOR MONITORING AND MODULATING BLOCKING A GENE
WO2006037462A3 (en) Cancer markers
MX2007012782A (es) Metodos y acidos nucleicos para analisis de trastornos proliferativos celulares.
MX2007009809A (es) Amplificacion de sonda por seleccion.
WO2006089233A3 (en) Methods and systems for diagnosis, prognosis and selection of treatment of leukemia
WO2009059317A3 (en) Predicting amd with snps within or near c2, factor b, plekha1, htra1, prelp, or loc387715
WO2001076451A3 (en) Diagnosis of diseases associated with metabolism
WO2007058968A3 (en) Gene expression profiles and methods of use
WO2008061213A3 (en) Genetic variations associated with tumors
WO2005032495A8 (en) Gene expression profiles and methods of use
WO2004078035A3 (en) Expression profiles for breast cancer and methods of use
WO2007085497A3 (en) Markers for the prediction of outcome of anthracycline treatment
WO2009120712A3 (en) Compositions and methods for diagnosing and treating melanoma
WO2008112898A3 (en) Genetic alterations on chromosome 12 and methods of use thereof for the diagnosis and treatment of type 1 diabetes
MX2009004382A (es) Variaciones geneticas asociadas con tumores.
WO2007120955A3 (en) Genes affecting human memory performance
WO2007063405A3 (en) Diagnosis and treatment of exocrine pancreatic dysfunction and diabetes using human cel gene
WO2009140679A3 (en) Genetic alterations on chromosomes 21q, 6q and 15q and methods of use thereof for the diagnosis and treatment of type i diabetes
WO2008048902A3 (en) Methods of using single nucleotide polymorphisms in the il23r gene to predict or diagnose inflammatory bowel disease